Second and subsequent lines of systemic therapy in endometrial cancer – a real-life clinical experience
Klinicka onkologie · 15.06.2026 · 39 (3) · 184-194
DOI: 10.48095/ccko2026184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinicka onkologie, online erschienen am 15.06.2026. Verfasst von Bednaříková Markéta und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Neoplasm Recurrence, Local, Antineoplastic Combined Chemotherapy Protocols.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Markéta, B., Michaela, K., Petra, O., Jitka, H., Lucie, E., Michal, F., Martina, T., Luboš, M., & Vít, W. (2026). Second and subsequent lines of systemic therapy in endometrial cancer – a real-life clinical experience. Klinicka onkologie, 39(3), 184-194. https://doi.org/10.48095/ccko2026184
Vancouver
Markéta B, Michaela K, Petra O, Jitka H, Lucie E, Michal F, et al. Second and subsequent lines of systemic therapy in endometrial cancer – a real-life clinical experience. Klinicka onkologie. 2026;39(3):184-194. doi:10.48095/ccko2026184
BibTeX
@article{Markta2026,
author = {Markéta, Bednaříková and Michaela, Koblížková and Petra, Ovesná and Jitka, Hausnerová and Lucie, Ehrlichová and Michal, Felsinger and Martina, Tomková and Luboš, Minář and Vít, Weinberger},
title = {Second and subsequent lines of systemic therapy in endometrial cancer – a real-life clinical experience},
journal = {Klinicka onkologie},
year = {2026},
volume = {39},
number = {3},
pages = {184--194},
doi = {10.48095/ccko2026184}
}
EUVIMED